Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neil O Fishman

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
Medicine|June 4, 2008
Treatment and outcomes for patients with bacteremic pneumococcal pneumoniaCatherine M Berjohn, Neil O Fishman, Marshall M Joffe, et al.
Infection Control and Hospital Epidemiology|August 12, 2014
Usability and impact of a computerized clinical decision support intervention designed to reduce urinary catheter utilization and catheter-associated urinary tract infectionsCharles A Baillie, Mika Epps, Asaf Hanish, et al.
Infection Control and Hospital Epidemiology|November 13, 2007
Impact of automatic orders to discontinue vancomycin therapy on vancomycin use in an antimicrobial stewardship programDenise M Connor, Shawn Binkley, Neil O Fishman, et al.
Infection Control and Hospital Epidemiology|July 11, 2013
Public reporting of hospital-acquired infections is not associated with improved processes or outcomesDarren R Linkin, Neil O Fishman, Judy A Shea, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2003
Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporinsEbbing Lautenbach, Lori A LaRosa, Ann Marie Marr, et al.
The American Journal of Medicine|June 6, 2006
Fluoroquinolone-resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impactLeanne B Gasink, Neil O Fishman, Mark G Weiner, et al.
Archives of Internal Medicine|March 8, 2003
Fluoroquinolone utilization in the emergency departments of academic medical centers: prevalence of, and risk factors for, inappropriate useEbbing Lautenbach, Lori A Larosa, Nishaminy Kasbekar, et al.
Infection Control and Hospital Epidemiology|February 25, 2009
Stockpiling drugs for an avian influenza outbreak: examining the surge in oseltamivir prescriptions during heightened media coverage of the potential for a worldwide pandemicLeanne B Gasink, Darren R Linkin, Neil O Fishman, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2006
Duration of outpatient fecal colonization due to Escherichia coli Isolates with decreased susceptibility to fluoroquinolones: longitudinal study of patients recently discharged from the hospitalEbbing Lautenbach, Pam Tolomeo, Xiangqun Mao, et al.
Infection Control and Hospital Epidemiology|January 10, 2012
Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremiaKara B Mascitti, Paul H Edelstein, Neil O Fishman, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
Medicine|June 4, 2008
Treatment and outcomes for patients with bacteremic pneumococcal pneumoniaCatherine M Berjohn, Neil O Fishman, Marshall M Joffe, et al.
Infection Control and Hospital Epidemiology|August 12, 2014
Usability and impact of a computerized clinical decision support intervention designed to reduce urinary catheter utilization and catheter-associated urinary tract infectionsCharles A Baillie, Mika Epps, Asaf Hanish, et al.
Infection Control and Hospital Epidemiology|November 13, 2007
Impact of automatic orders to discontinue vancomycin therapy on vancomycin use in an antimicrobial stewardship programDenise M Connor, Shawn Binkley, Neil O Fishman, et al.
Infection Control and Hospital Epidemiology|July 11, 2013
Public reporting of hospital-acquired infections is not associated with improved processes or outcomesDarren R Linkin, Neil O Fishman, Judy A Shea, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 5, 2003
Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporinsEbbing Lautenbach, Lori A LaRosa, Ann Marie Marr, et al.
The American Journal of Medicine|June 6, 2006
Fluoroquinolone-resistant Pseudomonas aeruginosa: assessment of risk factors and clinical impactLeanne B Gasink, Neil O Fishman, Mark G Weiner, et al.
Archives of Internal Medicine|March 8, 2003
Fluoroquinolone utilization in the emergency departments of academic medical centers: prevalence of, and risk factors for, inappropriate useEbbing Lautenbach, Lori A Larosa, Nishaminy Kasbekar, et al.
Infection Control and Hospital Epidemiology|February 25, 2009
Stockpiling drugs for an avian influenza outbreak: examining the surge in oseltamivir prescriptions during heightened media coverage of the potential for a worldwide pandemicLeanne B Gasink, Darren R Linkin, Neil O Fishman, et al.
Antimicrobial Agents and Chemotherapy|September 20, 2006
Duration of outpatient fecal colonization due to Escherichia coli Isolates with decreased susceptibility to fluoroquinolones: longitudinal study of patients recently discharged from the hospitalEbbing Lautenbach, Pam Tolomeo, Xiangqun Mao, et al.
Infection Control and Hospital Epidemiology|January 10, 2012
Prior vancomycin use is a risk factor for reduced vancomycin susceptibility in methicillin-susceptible but not methicillin-resistant Staphylococcus aureus bacteremiaKara B Mascitti, Paul H Edelstein, Neil O Fishman, et al.
Pageof 8